Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Berchuck

Showing results (441-450 of 683) with videos related to

Pageof 69
Sort By:
Targeted Oncology|January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian CancersCatherine H Watson, Gloria Broadwater, Janice Wong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 23, 2024
Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression PlatformsNatalie R Davidson, Mollie E Barnard, Ariel A Hippen, et al.
Gynecologic Oncology|October 9, 2007
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerZhen Zhang, Yinhua Yu, Fengji Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Gynecologic Oncology|August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approachesLauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platformsNatalie R Davidson, Mollie E Barnard, Ariel A Hippen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported raceKatherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
Pageof 69

Showing results (441-450 of 683) with videos related to

Sort By:
Pageof 69
Targeted Oncology|January 5, 2021
Results and Clinical Utilization of Foundation Medicine Molecular Tumor Profiling in Uterine and Ovarian CancersCatherine H Watson, Gloria Broadwater, Janice Wong, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 3, 2006
Identification of genes associated with ovarian cancer metastasis using microarray expression analysisJ M Lancaster, H K Dressman, J P Clarke, et al.
Cell Reports|July 29, 2022
Reciprocal SOX2 regulation by SMAD1-SMAD3 is critical for anoikis resistance and metastasis in cancerZainab Shonibare, Mehri Monavarian, Kathleen O'Connell, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 23, 2024
Molecular Subtypes of High-Grade Serous Ovarian Cancer across Racial Groups and Gene Expression PlatformsNatalie R Davidson, Mollie E Barnard, Ariel A Hippen, et al.
Gynecologic Oncology|October 9, 2007
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancerZhen Zhang, Yinhua Yu, Fengji Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 8, 2005
Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colonRebecca T Marquez, Keith A Baggerly, Andrea P Patterson, et al.
Gynecologic Oncology|August 20, 2018
Histotype classification of ovarian carcinoma: A comparison of approachesLauren C Peres, Kara L Cushing-Haugen, Michael Anglesio, et al.
Journal for Immunotherapy of Cancer|February 3, 2024
Comprehensive multiplexed autoantibody profiling of patients with advanced urothelial cancerPraful Ravi, Dory Freeman, Jonathan Thomas, et al.
Biorxiv : the Preprint Server for Biology|November 14, 2023
Molecular subtypes of high-grade serous ovarian cancer across racial groups and gene expression platformsNatalie R Davidson, Mollie E Barnard, Ariel A Hippen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 4, 2025
Homologous recombination deficiency and survival in ovarian high-grade serous carcinoma by self-reported raceKatherine A Lawson-Michod, Courtney E Johnson, Mollie E Barnard, et al.
Pageof 69